The TRULICITY 1.5 MG Diaries
The demo achieved the two its Principal endpoints, with semaglutide two.four mg demonstrating statistically sizeable and outstanding advancements in liver fibrosis without any worsening of steatohepatitis, in addition to resolution of steatohepatitis with no worsening of liver fibrosis in people with MASH as compared to placebo.oneRetain all appoin